OpenAI: new drugs take 10–15 years, AI agents can fix fragmented workflows
Dr_Singularity · x · 2026-10-21
OpenAI elaborated on the Orchestra Bio acquisition: developing a new medicine takes roughly 10–15 years on average from target discovery to US regulatory approval, requiring orchestration across internal teams and external partners on disconnected systems. The company argues AI is at an inflection point to take on these specialized tasks and complex workflows.
Related event: OpenAI Acquires Orchestra Bio to Bring AI Agents into Drug Development(13 posts)→
More from Companies & People
- PyTorch Foundation ecosystem grows 2.4x contributors across six projects including vLLM and Ray — PyTorch · 2026-10-21
- AI creator Bilawal Sidhu crosses 1M followers on TikTok with 9.8M likes — bilawalsidhu · 2026-10-21
- Jensen Huang: every company will have two factories, one real and one digital — round · 2026-10-21
- Palo Alto, not SF, is now the hottest neighborhood for new AI labs — infoxiao · 2026-10-21
- Ex-Twitter engineer credits X's growth to the long-delayed Android rewrite — Scobleizer · 2026-10-21
- Walden Robotics CTO joins Long Horizon panel on large behavior models with Rodney Brooks — adnothing · 2026-10-21